Compare SFBS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SFBS | STVN |
|---|---|---|
| Founded | 2005 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Major Banks | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.2B |
| IPO Year | 2014 | 2021 |
| Metric | SFBS | STVN |
|---|---|---|
| Price | $80.04 | $17.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $87.50 | $23.75 |
| AVG Volume (30 Days) | 257.3K | ★ 712.6K |
| Earning Date | 04-21-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.90% | 0.36% |
| EPS Growth | ★ 21.63 | N/A |
| EPS | ★ 5.06 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.30 | $8.42 |
| Revenue Next Year | $10.30 | $9.27 |
| P/E Ratio | ★ $15.81 | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.48 | $13.91 |
| 52 Week High | $90.64 | $28.00 |
| Indicator | SFBS | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 57.47 |
| Support Level | $78.37 | $13.91 |
| Resistance Level | $84.75 | $26.61 |
| Average True Range (ATR) | 2.86 | 0.78 |
| MACD | -0.97 | 0.23 |
| Stochastic Oscillator | 16.04 | 94.19 |
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.